


Learning that you or someone you care about has a tumor is never easy, especially if it is difficult to treat.
St. Joseph's Hospital was the first in the Upper Midwest to offer the revolutionary technology ofthe CyberKnife® Stereotactic Radiosurgery System. Since opening the CyberKnife Center, we've treated more than 900 patients.
The CyberKnife gives patients new hope for the treatment of tumors and lesions that previously have been diagnosed as inoperable or untreatable with existing technology.
The CyberKnife surgical team
Unlike conventional surgery, CyberKnife procedures don't require large incisions or blood loss. Most patients require one to five treatments, each lasting 45 to 90 minutes per tumor.
The CyberKnife procedure is usually painless and patients go home the same day. Find out about the treatment process.
Treatment with CyberKnife® results in potentially fewer complications than invasive surgery and often allows patients to have a better quality of life during and after treatment.
Other benefits:
CyberKnife technology is approved by the U.S. Food and Drug Administration (FDA) to treat tumors and lesions throughout the body.
St. Joseph's Hospital uses CyberKnife to treat a variety of tumors, including those in the:
When appropriate, we can also treat tumors in other areas of the body.
The CyberKnife Center at St. Joseph's Hospital was developed in partnership between the HealthEast Neurovascular Institute (now the National Brain Aneurysm Center) and HealthEast Cancer Care. Our programs have developed a reputation for clinical excellence and compassionate care.